Vivos Therapeutics Past Earnings Performance
Past criteria checks 0/6
Vivos Therapeutics's earnings have been declining at an average annual rate of -12.1%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 11.5% per year.
Key information
-12.1%
Earnings growth rate
6.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 11.5% |
| Return on equity | -3,304.9% |
| Net Margin | -98.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
It's Down 44% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Apr 25
It's Down 48% But Vivos Therapeutics, Inc. (NASDAQ:VVOS) Could Be Riskier Than It Looks
Feb 02Fewer Investors Than Expected Jumping On Vivos Therapeutics, Inc. (NASDAQ:VVOS)
Apr 18Vivos Therapeutics again delays Q2 2022 results
Aug 23Vivos Therapeutics signs exclusive distribution agreement with GM Instruments for US and Canada
Jun 29Vivos Therapeutics, Inc. (NASDAQ:VVOS) Analysts Are More Bearish Than They Used To Be
May 21Vivos Therapeutics: First Take After The Broad Market Sell-Off
Mar 06Vivos Therapeutics: Reimagining Sleep
Jul 30Vivos Therapeutics prices $24M follow-on offering
May 07Revenue & Expenses BreakdownBeta
How Vivos Therapeutics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 14 | -14 | 25 | 0 |
| 30 Sep 23 | 15 | -15 | 27 | 0 |
| 30 Jun 23 | 15 | -19 | 30 | 0 |
| 31 Mar 23 | 16 | -20 | 33 | 0 |
| 31 Dec 22 | 16 | -24 | 34 | 0 |
| 30 Sep 22 | 16 | -25 | 36 | 0 |
| 30 Jun 22 | 17 | -25 | 36 | 0 |
| 31 Mar 22 | 17 | -22 | 34 | 0 |
| 31 Dec 21 | 17 | -20 | 31 | 0 |
| 30 Sep 21 | 16 | -24 | 27 | 0 |
| 30 Jun 21 | 15 | -21 | 23 | 0 |
| 31 Mar 21 | 13 | -19 | 20 | 0 |
| 31 Dec 20 | 13 | -18 | 18 | 0 |
| 30 Sep 20 | 13 | -9 | 18 | 0 |
| 30 Jun 20 | 13 | -11 | 19 | 0 |
| 31 Mar 20 | 12 | -12 | 19 | 0 |
| 31 Dec 19 | 11 | -12 | 18 | 0 |
| 31 Dec 18 | 4 | -9 | 10 | 0 |
Quality Earnings: VVOS is currently unprofitable.
Growing Profit Margin: VVOS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VVOS is unprofitable, and losses have increased over the past 5 years at a rate of 12.1% per year.
Accelerating Growth: Unable to compare VVOS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VVOS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (12.5%).
Return on Equity
High ROE: VVOS has a negative Return on Equity (-3304.87%), as it is currently unprofitable.